ÂÜÀòÂÒÂ×

BT Slingsby

Founder & Executive Chair at Mineralys Therapeutics

Dr. Slingsby is Founder & Managing Partner at Catalys Pacific. He served as interim CEO during the creation and incubation of Mineralys. Previous to Catalys Pacific, he founded the GHIT Fund – the world’s first public-private fund focused on the development of new medicines for low- and middle-income countries. Dr. Slingsby graduated from Brown University with honors, earned his MPH and PhD from Kyoto University and the University of Tokyo, and received his MD with honors from the George Washington University; he has authored over 50 peer-reviewed articles and currently serves as Invited Professor at the Graduate School of Medicine of Kyoto University and University of Osaka.